Indication
Schizophrenia
Assets addressing this indication.
Total attributable cost
$36.7B
$11,952/patient
Drug spend
$15.6B
$5,069/patient
42% of total cost is drugs
All severities · US
Indication
Assets addressing this indication.
Total attributable cost
$36.7B
$11,952/patient
Drug spend
$15.6B
$5,069/patient
42% of total cost is drugs
All severities · US
68 of 68 assets